Our Team
David Schwartz, PhD
Co-Founder, CEO, CSO
Has over 30 years experience developing novel bioconjugation chemistries for both in vivo therapeutics and in vivo and in vitro diagnostics; leads the team at Cell IDx. Dr. Schwartz applied his extensive background in bio-organic chemistry, synthetic organic chemistry, and in vitro and in vivo diagnostics to develop multiplex immunofluorescence technologies.
Helen Snyder, PhD
Director of Business Development & Strategic Partnerships
Received her PhD in immunology from the University of Cambridge, UK, and trained as a postdoctoral fellow at Scripps Research Institute, La Jolla, California. Dr. Snyder has over 30 years’ experience in immunology research, reagent development, preclinical development of biotherapeutics, and business development of immunoassay and immunodiagnostic products.
Stephen J. Kron, MD, PhD
Co-Founder
Dr. Kron received his MD, PhD in Cell Biology from Stanford University and is currently a professor in the Department of Molecular Genetics and Cell Biology at The University of Chicago. Steve has published over a hundred papers and reviews, and is an inventor on multiple patents, several of which have been commercialized.
Cell IDx is a Registered Supplier on
and
© 2016–23 Cell IDx. Cell IDx, UltraPlex, UltraPolymer, UltraTag, and Path IDx are trademarks of Cell IDx, Inc. All Rights Reserved. Privacy Policy | Terms of Service Website by Fifth Street Design.